135 related articles for article (PubMed ID: 26971993)
1. Diagnostic accuracy of serum biomarkers for head and neck cancer: A systematic review and meta-analysis.
Guerra EN; Rêgo DF; Elias ST; Coletta RD; Mezzomo LA; Gozal D; De Luca Canto G
Crit Rev Oncol Hematol; 2016 May; 101():93-118. PubMed ID: 26971993
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic capability of salivary biomarkers in the assessment of head and neck cancer: A systematic review and meta-analysis.
Guerra EN; Acevedo AC; Leite AF; Gozal D; Chardin H; De Luca Canto G
Oral Oncol; 2015 Sep; 51(9):805-18. PubMed ID: 26170140
[TBL] [Abstract][Full Text] [Related]
3. Head and neck cancer biomarkers: Systematic review and meta-analysis.
Marakala V
Clin Chim Acta; 2023 Mar; 542():117280. PubMed ID: 36878379
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review.
Ipenburg NA; Koole K; Liem KS; van Kempen PM; Koole R; van Diest PJ; van Es RJ; Willems SM
Target Oncol; 2016 Feb; 11(1):17-27. PubMed ID: 26115874
[TBL] [Abstract][Full Text] [Related]
5. Biomarker quantification by multiplexed quantum dot technology for predicting lymph node metastasis and prognosis in head and neck cancer.
Hu Z; Qian G; Müller S; Xu J; Saba NF; Kim S; Chen Z; Jiang N; Wang D; Zhang H; Lane K; Hoyt C; Shin DM; Chen ZG
Oncotarget; 2016 Jul; 7(28):44676-44685. PubMed ID: 27172790
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation biomarkers in peripheral blood of patients with head and neck squamous cell carcinomas. A systematic review.
Danstrup CS; Marcussen M; Pedersen IS; Jacobsen H; Dybkær K; Gaihede M
PLoS One; 2020; 15(12):e0244101. PubMed ID: 33332423
[TBL] [Abstract][Full Text] [Related]
7. Identification of patients with head and neck cancer using serum protein profiles.
Wadsworth JT; Somers KD; Stack BC; Cazares L; Malik G; Adam BL; Wright GL; Semmes OJ
Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):98-104. PubMed ID: 14732777
[TBL] [Abstract][Full Text] [Related]
8. Serum biomarkers in head and neck squamous cell cancer.
Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in the assessment of oral mucositis in head and neck cancer patients: a systematic review and meta-analysis.
Normando AGC; Rocha CL; de Toledo IP; de Souza Figueiredo PT; Dos Reis PED; De Luca Canto G; Guerra ENS
Support Care Cancer; 2017 Sep; 25(9):2969-2988. PubMed ID: 28623401
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of serum squamous cell carcinoma antigen for hepatocellular carcinoma: a systematic review and meta-analysis.
Yu J; Wang ZJ; Chen LH; Dong WZ
Scand J Clin Lab Invest; 2017 Feb; 77(1):8-14. PubMed ID: 27762143
[TBL] [Abstract][Full Text] [Related]
11. Protein biomarker discovery for head and neck cancer.
Schaaij-Visser TB; Brakenhoff RH; Leemans CR; Heck AJ; Slijper M
J Proteomics; 2010 Sep; 73(10):1790-803. PubMed ID: 20139037
[TBL] [Abstract][Full Text] [Related]
12. Xenograft assessment of predictive biomarkers for standard head and neck cancer therapies.
Stein AP; Swick AD; Smith MA; Blitzer GC; Yang RZ; Saha S; Harari PM; Lambert PF; Liu CZ; Kimple RJ
Cancer Med; 2015 May; 4(5):699-712. PubMed ID: 25619980
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of Cyfra 21-1 for head and neck squamous cell carcinoma: a meta-analysis.
Wang YX; Hu D; Yan X
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2383-9. PubMed ID: 24065233
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic and prognostic biomarkers in head and neck squamous cell carcinoma].
Lehnerdt G; Hoffmann TK; Mattheis S; Brandau S; Zeidler R; Lang S
HNO; 2010 Jul; 58(7):713-23; quiz 724-5. PubMed ID: 20544170
[TBL] [Abstract][Full Text] [Related]
15. Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines.
Kalish LH; Kwong RA; Cole IE; Gallagher RM; Sutherland RL; Musgrove EA
Clin Cancer Res; 2004 Nov; 10(22):7764-74. PubMed ID: 15570011
[TBL] [Abstract][Full Text] [Related]
16. Detection of CAF-1/p60 in peripheral blood as a potential biomarker of HNSCC tumors.
Merolla F; Ilardi G; Di Spigna G; Russo D; Martino F; Varricchio S; Dell'Aversana GO; Mascolo M; Covelli B; Caltabiano R; Broggi G; Audino G; Celetti A; Postiglione L; Staibano S
Oral Oncol; 2021 Sep; 120():105367. PubMed ID: 34237585
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of head and neck squamous cell cancer biomarkers.
Polanska H; Raudenska M; Gumulec J; Sztalmachova M; Adam V; Kizek R; Masarik M
Oral Oncol; 2014 Mar; 50(3):168-77. PubMed ID: 24382422
[TBL] [Abstract][Full Text] [Related]
18. Tumor associated macrophages induce epithelial to mesenchymal transition via the EGFR/ERK1/2 pathway in head and neck squamous cell carcinoma.
Gao L; Zhang W; Zhong WQ; Liu ZJ; Li HM; Yu ZL; Zhao YF
Oncol Rep; 2018 Nov; 40(5):2558-2572. PubMed ID: 30132555
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor (EGFR) mutations as biomarker for head and neck squamous cell carcinomas (HNSCC).
Nagalakshmi K; Jamil K; Pingali U; Reddy MV; Attili SS
Biomarkers; 2014 May; 19(3):198-206. PubMed ID: 24712396
[TBL] [Abstract][Full Text] [Related]
20. Effects of metformin on head and neck cancer: a systematic review.
Rêgo DF; Pavan LM; Elias ST; De Luca Canto G; Guerra EN
Oral Oncol; 2015 May; 51(5):416-22. PubMed ID: 25636350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
